The grant was awarded to researcher Robert Garry, PhD, professor of microbiology and immunology, for two projects related to Lassa fever. Dr. Garry received $5.72 million to study an antibody drug and $6.32 million to develop a vaccine.
“These two projects complement each other. In West Africa, we need a drug to treat acutely infected patients as well as a preventative measure to stop it,” Dr. Garry told News Medical. “Vaccine initiatives in rural Africa are difficult so you are never going to be able to vaccinate everyone. You need to be able to treat people when they get sick.”
More articles on healthcare finance:
Bankrupt Arizona hospital asks court to end levy for Medicaid expansion
W.Va clinic receives $2M grant
Mercy Health System adopts new billing system
